News
-
-
-
-
PRESS RELEASE
Nemetschek Group: Successful start to the year in Q1 2024 with double-digit operational revenue growth at a continued high profitability level
Nemetschek Group reports successful Q1 2024 with double-digit revenue growth and high profitability. Focus on subscription & SaaS models driving growth and efficiency -
PRESS RELEASE
SIG Group AG: Stable volumes, initial signs of growth recovery, progress on production footprint
SIG Group AG reports stable volumes and initial signs of growth recovery in Q1 2024, with progress on production footprint. CEO expects volume growth acceleration throughout the year and improved profitability in the second half -
-
-
-
-
PRESS RELEASE
Newron announces positive top-line results from potentially pivotal Phase II/III study 008A with evenamide in schizophrenia patients
Newron Pharmaceuticals S.p.A. announces positive Phase II/III study results of evenamide in schizophrenia patients, meeting primary and key secondary endpoints with good tolerability